MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1371/journal.pone.0346868

Медицинская библиотека · PloS one · 2026

The Asanté™ HIV-1 Rapid Recency® Assay is reliable, feasible, and acceptable for use at the point-of-care in Lusaka, Zambia.

Iyer Shilpa S, Pry Jake M, Kapesa Herbert, Moono Misinzo, Mwila Chilambwe, Frimpong Christiana, Nanyangwe Mirriam, Phiri Lumbani, Ngandu Ruth, Sakanya Precious, Mwansa Sharon, Phiri Talandila, Haciwa Mizinga, Maritim Patricia, Lee Kemba, Arons Melissa, Aholou Tiffiany, Minchella Peter, Savory-van Huis Theodora, Bolton Carolyn, Herce Michael E

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Zambia established a recent infection testing algorithm (RITA) incorporating a novel point-of-care (POC) rapid test-the Asanté™ HIV-1 Rapid Recency® Assay (RTRI)-plus a HIV-1 viral load (VL) test to distinguish recent (≤12 months) from long-term (>12 months) HIV acquisition. This study evaluated the field performance of RTRI when implemented by healthcare workers at the POC.

METHODS

We enrolled individuals newly diagnosed with HIV between 20 May 2021 and 10 March 2022 at two Ministry of Health facilities in Lusaka, Zambia. Participants received on-site RTRI testing and provided an additional sample for repeat RTRI and VL testing at a central laboratory. Final recent infection testing algorithm (RITA) results were returned to the study sites and were made available to clients at their study follow-up visit. Agreement between POC- and laboratory-RTRI was assessed using Cohen's Kappa. We compared recent versus long-term HIV classification across testing locations using the national RITA as the reference standard. Four focus group discussions (FGDs) with health staff explored perceptions surrounding POC-RTRI implementation.

RESULTS

Agreement between POC and laboratory RTRI was 96.5%, with a Kappa of 0.812 (95% CI: 0.704-0.920). The POC-RTRI results indicated numerically more recent infections than laboratory-RTRI (30 vs 27), with three POC-RTRI false positives resulting in reduced sensitivity 85.0% for the POC-RTRI compared to 100.0% sensitivity for the laboratory-RTRI against the RITA reference standard. FGD participants (n = 28) agreed that POC RTRI was feasible and acceptable with adequate training, human resources, client counselling, and quality assurance measures.

CONCLUSION

There was strong concordance between POC- and laboratory-RTRI results. The findings support the feasibility of implementing RTRI at POC by non-laboratory health workers, provided adequate training and health system resources are in place.

Для цитирования: Iyer Shilpa S, Pry Jake M, Kapesa Herbert, Moono Misinzo, Mwila Chilambwe, Frimpong Christiana, Nanyangwe Mirriam, Phiri Lumbani, Ngandu Ruth, Sakanya Precious, Mwansa Sharon, Phiri Talandila, Haciwa Mizinga, Maritim Patricia, Lee Kemba, Arons Melissa, Aholou Tiffiany, Minchella Peter, Savory-van Huis Theodora, Bolton Carolyn, Herce Michael E. The Asanté™ HIV-1 Rapid Recency® Assay is reliable, feasible, and acceptable for use at the point-of-care in Lusaka, Zambia.. PloS one. 2026. DOI: 10.1371/journal.pone.0346868.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.